KKR FS Income Trust has declared a monthly dividend of $0.225 per share on its common shares of beneficial interest, a move that underscores the company's ongoing commitment to returning value to its shareholders. This dividend is set to be paid on or about December 29, 2026, to shareholders of record as of the close of business on November 30, 2026.
The decision to issue a dividend reflects KKR FS Income Trust's financial health and ability to generate consistent income, which is crucial for its investors. Shareholders will have the option to receive their dividend payments in cash or reinvest them in additional shares under the company's distribution reinvestment plan.
Background
KKR FS Income Trust, incorporated in Delaware, operates as an emerging growth company. The trust focuses on providing attractive risk-adjusted returns to its investors through investments in a diversified portfolio of income-generating assets. The company has been active in the financial markets, regularly filing reports with the SEC to keep its investors informed.
What the Filing Says
According to the recent filing (accession number 0001104659-26-119971), the Board of Trustees declared the monthly dividend on October 28, 2026. The filing states, "Shareholders may receive the dividend payments in cash or in shares of the Company’s common shares of beneficial interest in accordance with their election under the Company’s distribution reinvestment plan." This flexibility allows shareholders to choose the option that best suits their financial strategies.
Impact
This dividend declaration may positively impact current and potential investors, as it signals KKR FS Income Trust's commitment to shareholder returns. It may also influence other companies in the financial services sector, particularly those that are similarly structured or compete for investor capital.
What's Next
The filing does not say what happens next regarding future dividends or company plans. However, investors will likely be monitoring KKR FS Income Trust's performance and any subsequent filings for further updates.
Read Next
Pellicciotti reports stock transaction at Air Products
Northern Lights Fund Trust II files NPORT-P report for Q3 2026
Northern Lights Fund Trust II reports latest financials
Northern Lights Fund Trust II reports asset updates in NPORT-P
X4 Pharmaceuticals to Host Investor Day on October 29, 2026
John Hancock Funds III Updates Prospectus with Name Change










